| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,259 |
5,690 |
$309K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,135 |
1,851 |
$138K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
469 |
416 |
$29K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,792 |
1,432 |
$17K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
176 |
157 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
418 |
295 |
$6K |
| 95923 |
|
51 |
47 |
$3K |
| 93922 |
|
51 |
47 |
$2K |
| 95921 |
|
51 |
47 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
52 |
44 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$922.34 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
57 |
50 |
$565.31 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
61 |
29 |
$532.30 |
| 36415 |
Collection of venous blood by venipuncture |
144 |
122 |
$404.03 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
12 |
12 |
$402.24 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
39 |
32 |
$381.78 |
| 90686 |
|
47 |
43 |
$179.29 |
| 90688 |
|
17 |
13 |
$93.23 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
346 |
310 |
$81.50 |
| 81025 |
|
13 |
12 |
$79.52 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
49 |
42 |
$68.38 |
| 81003 |
|
16 |
15 |
$18.86 |